3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
38
Thoracic
5
Breast
4
Gynecologic
3
Dermatologic
3
Sarcoma
2
Lymphoid
2
Head & Neck
2
Genitourinary
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Mesothelioma, Malignant
9
Retinoblastoma
4
Mesothelioma
4
Solid Tumor
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Neoplasms
2
Lung Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Solid Tumors, Adult
1
Solid Tumor Regardless of Localization and Stage
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
pembrolizumab
10
belinostat
2
Plicamycin
2
Decitabine
2
Celecoxib
2
tocilizumab
1
spartalizumab
1
obinutuzumab
1
naptumomab estafenatox
1
epacadostat
1
entinostat
1
durvalumab
1
alvocidib
1
Tetrahydrouridine
1
Tablets
1
Surgical Procedures, Operative
1
Quality of Life
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Levoleucovorin
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
Immunotherapy, Adoptive
1
Immunotherapy
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Drug Therapy
×
Other solid neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled